CAT
69
11
D
46
3
CL
62
-2
CCL
82
-4
CMA
67
2
APD
52
2
DG
72
4
AMT
30
4
AKAM
59
-2
CAG
36
2
CF
36
-2
ALL
57
-3
ADI
73
-3
CVX
29
-2
BDX
61
2
AES
57
2
DOV
71
10
DRI
58
-5
AFL
45
-3
DIS
70
-2
CAT
69
11
D
46
3
CL
62
-2
CCL
82
-4
CMA
67
2
APD
52
2
DG
72
4
AMT
30
4
AKAM
59
-2
CAG
36
2
CF
36
-2
ALL
57
-3
ADI
73
-3
CVX
29
-2
BDX
61
2
AES
57
2
DOV
71
10
DRI
58
-5
AFL
45
-3
DIS
70
-2
Financhill
Back

INNOVATE Corp. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
39

VATE
INNOVATE Corp.

Last Price:
$4.85
Seasonality Move:
11.43%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
39
INNOVATE Corp. (VATE) is a Sell

Is INNOVATE Corp. a Buy, Sell or Hold?

  • The current INNOVATE Corp. [VATE] share price is $4.92. The Score for VATE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • VATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VATE Stock Price Chart

What is INNOVATE Corp.'s stock price today?

  • The INNOVATE Corp. share price today is $4.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VATE is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

VATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.37 Buy
Relative Strength Index (14 RSI): 49.71 Sell
Chaikin Money Flow: -6489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.63 - 5.17) Buy
Bollinger Bands (100): (4.59 - 5.37) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

VATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.93 Sell
20-day SMA: 4.85 Buy
50-day SMA: 5.09 Sell
200-day SMA: 5.58 Sell
8-day EMA: 4.14 Buy
20-day EMA: 2.52 Buy
50-day EMA: 1.22 Buy
200-day EMA: 0.34 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

INNOVATE Corp. Earnings Growth & VATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

INNOVATE Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):